Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.
Aging (Albany NY)
; 15(20): 11690-11691, 2023 10 30.
Article
in En
| MEDLINE
| ID: mdl-37906268
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Aging (Albany NY)
Journal subject:
GERIATRIA
Year:
2023
Document type:
Article